SCHEMBL6646048

SCHEMBL6646048

Cc1ccc(C(=O)Nc2ccc3c(c2)CCN3Cc2ccccn2)c(N2CCC(C)CC2)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 1/20 0.45
▸ ERBB2 P04626 1/20 0.45
▸ ERBB4 Q15303 1/20 0.45
▸ SCN10A Q9Y5Y9 3/20 0.42
▸ ALDH1A1 P00352 1/20 0.41
▸ KIF18A Q8NI77 4/20 0.39
▸ POLB P06746 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ MAPT P10636 2/20 0.39
▸ TP53 P04637 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ ALOX5 P09917 1/20 0.38
▸ EPHX2 P34913 1/20 0.38
▸ GRM4 Q14833 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ TRPV1 Q8NER1 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ SMO Q99835 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6646615 0.92 SCN10A (0.41) EGFRERBB2ERBB4SCN10AALDH1A1
SCHEMBL6647760 0.88 SCN10A (0.45) SCN10AALDH1A1KIF18APOLBMAPT
SCHEMBL6646845 0.88 EIF2AK3 (0.42) SCN10AALDH1A1KIF18APOLBMAPT
SCHEMBL6643712 0.87 SCN10A (0.42) SCN10AALDH1A1KIF18APOLBMAPT
SCHEMBL6645188 0.81 SCN10A (0.42) SCN10AALDH1A1KIF18APOLBMAPT
SCHEMBL6646611 0.80 SCN10A (0.46) SCN10AMAPTTP53SMN1; SMN2TRPV1
SCHEMBL6644233 0.80 MAPT (0.55) SCN10AALDH1A1MAPTTP53SMN1; SMN2
SCHEMBL6647122 0.79 SCN10A (0.49) SCN10AALDH1A1KIF18AMAPTTP53
SCHEMBL6644190 0.79 OGA (0.52) SCN10AALDH1A1POLBMAPTSMN1; SMN2
SCHEMBL6647110 0.79 KIF18A (0.40) SCN10AALDH1A1KIF18APOLBTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040133008-A1 Amide compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-07-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040133008-A1 Amide compounds APOB, APOL1, LDLR EGFR 851/4885ERBB2 198/4885ERBB4 1315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback